Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Shares with over 50 years of consecutive dividend increases rarely go under the radar. But that might be what’s happening ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

PlayStation showcased 007 First Light at its June 4th State of Play event. The developer revealed the James Bond spy game ...

Results from the Phase Ib/II CARTITUDE-1 trial demonstrated that a single infusion of Carvykti delivered durable, ...

For Q1 of 2025, globally announced M&A activity totaled $885 billion, a 15% increase relative to Q1 of 2024. Click here to ...

Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

Wall Street trading got off to a mixed start on Thursday after the blue-chip Dow Jones snapped its four-day win streak.

US stocks finished in the red on Thursday as investors turned cautious ahead of the non-farm payrolls report, while shares in ...

Johnson & Johnson’s Akeega from AMPLITUDE study shows improved efficacy in patients with HRR-mutated mHSPC: Beerse, Belgium Thursday, June 5, 2025, 12:00 Hrs [IST] Johnson & Joh ...

Jerina Vincent and her daughter Natania Julius burst into laughter and embraced. “Mom!” Julius said through an incredulous ...